• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oramed Pharmaceuticals Inc

+ Add to Watchlist

ORMP:US

5.1300 USD 0.2800 5.18%

As of 17:20:00 ET on 12/22/2014.

Snapshot for Oramed Pharmaceuticals Inc (ORMP)

Open: 5.3900 Day's Range: 4.8900 - 5.4100 Volume: 130,736
Previous Close: 5.4100 52wk Range: 4.8800 - 31.7300 1-Yr Rtn: -51.83%

Stock Chart for ORMP

No chart data available.
  • ORMP:US 5.0100
  • 1D
  • 1M
  • 1Y
5.4100
Interactive ORMP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORMP

Current P/E Ratio (ttm) -
Estimated P/E(08/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6200
Est. EPS (USD) (08/2015) -0.9200
Est. PEG Ratio -
Market Cap (M USD) 54.67
Shares Outstanding (M) 10.80
30 Day Average Volume 45,815
Price/Book (mrq) 2.4925
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORMP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ORMP

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Nadav KidronPresident/CEOYifat ZommerCFO/Treasurer/Secretary
Miriam KidronChief Medical & Tech OfficerJoshua Hexter "Josh"VP:Business Dev/COO
More Company Profile & Key Executives for ORMP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • ORMP News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil